2/253/615726885 |
您所在的位置：网站首页 › 2/253/615726885 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/24157723MicroRNAs in plasma and cerebrospinal fluid as potential …网页Recent reports suggested that microRNA (miRNA) profiling of biological fluids has emerged as a diagnostic tool for several pathologic conditions. In this study, we measured six candidate miRNAs (miR-9, miR-29a, miR-29b, miR-34a, miR-125b, and miR-146a) in plasma and cerebrospinal fluid (CSF) of AD and normal subjects by using quantitative ...
发布时间：2024-07-08data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/20144356Noninvasive glucose monitoring: a novel approach - PubMed网页2009年3月1日 · By using a combination of (three) independent technologies-ultrasonic, electromagnetic, and thermal-GlucoTrack presents a unique approach for a real-time, truly NI blood glucose spot measurement. Methods: Clinical trials were performed in two stages. Stage 1 was an initial method validation and performance verification of the device.
发布时间：2024-07-08data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/37925144Clinical Response and Remission in Patients With Severe …网页Anti-Asthmatic Agents. Biological Products. Clinical response was achieved in most adult patients initiating biologic therapy, and clinical remission was observed in 19% of the patients following 12 months of treatment. Further studies are required to assess the long-term outcome of achieving clinical remission with biologic therapy.
发布时间：2024-07-08